IA
COLL icon

IFP Advisors’s Collegium Pharmaceutical COLL Stock Holding History

IFP Advisors’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Hold
0
– – – 4080
2025
Q1 		– Sell
-8
Closed -$229 – 4379
2024
Q4 		$229 Buy
+8
New +$265 ﹤0.01% 3664
2023
Q1 		– Sell
-25
Closed -$3K – 3562
2022
Q4 		$3K Sell
25
-6
-19% -$121 ﹤0.01% 3988
2022
Q3 		$3K Buy
+31
New +$547 ﹤0.01% 4200
2018
Q4 		– Sell
-13,250
Closed -$195K – 3570
2018
Q3 		$195K Buy
13,250
+2,350
+22% +$41.7K 0.01% 1089
2018
Q2 		$260K Buy
10,900
+3,500
+47% +$86.1K 0.01% 935
2018
Q1 		$137K Hold
7,400
– – 0.01% 1191
2017
Q4 		$137K Hold
7,400
– – 0.01% 1200
2017
Q3 		$78K Buy
7,400
+1,000
+16% +$11K ﹤0.01% 1698
2017
Q2 		$80K Hold
6,400
– – ﹤0.01% 1660
2017
Q1 		$64K Buy
6,400
+200
+3% +$2.97K ﹤0.01% 1772
2016
Q4 		$97K Buy
6,200
+200
+3% +$3.32K ﹤0.01% 1480
2016
Q3 		$116K Buy
6,000
+400
+7% +$4.75K 0.01% 1285
2016
Q2 		$66K Buy
+5,600
New +$92.5K ﹤0.01% 1586

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

IFP Advisors's COLL Position: Q2 2025 in Review

IFP Advisors held its Collegium Pharmaceutical (COLL) position steady in Q2 2025 at 0 shares worth $1.36K. The position accounts for ﹤0.01% of the portfolio, ranked #4080.

IFP Advisors first reported a position in COLL in Q2 2016 and has held it in 13 quarters since. The position peaked at $260K in Q2 2018. 223 funds tracked by Wall St. Rank hold COLL as of Q2 2025.

  • IFP Advisors held 0 shares of Collegium Pharmaceutical worth $1.36K as of Q2 2025.
  • IFP Advisors left its Collegium Pharmaceutical share count unchanged in Q2 2025.
  • Collegium Pharmaceutical made up ﹤0.01% of IFP Advisors's portfolio in Q2 2025, its #4080 holding.
  • IFP Advisors first reported a position in Collegium Pharmaceutical in Q2 2016 and has held it in 13 quarters since.
  • IFP Advisors's Collegium Pharmaceutical position peaked at $260K in Q2 2018.
  • 223 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2025.

Based on IFP Advisors's 13F filing for Q2 2025, filed 24 Jul 2025.